Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes
- PMID: 26600045
- PMCID: PMC4880129
- DOI: 10.1210/jc.2015-3437
Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes
Abstract
Context: Roux-en-Y gastric bypass (RYGB) leads to high-turnover bone loss, but little is known about skeletal effects of laparoscopic adjustable gastric banding (LAGB) or mechanisms underlying bone loss after bariatric surgery.
Objective: To evaluate effects of RYGB and LAGB on fasting and postprandial indices of bone remodeling.
Design and setting: Ancillary investigation of a prospective study at 2 academic institutions.
Participants: Obese adults aged 21-65 years with type 2 diabetes who underwent RYGB (n = 11) or LAGB (n = 8).
Outcomes: Serum C-terminal telopeptide (CTX), procollagen type 1 N-terminal propeptide (P1NP), and PTH were measured during a mixed meal tolerance test at baseline, 10 days and 1 year after surgery. Changes in 25-hydroxyvitamin D, polypeptide YY (PYY), glucagon-like peptide-1, glucose-dependent insulinotropic peptide, and insulin were also assessed.
Results: Fasting CTX increased 10 days after RYGB but not LAGB (+69 ± 23% vs +12±12%, P < .001), despite comparable weight loss at that time. By 1 year, fasting CTX and P1NP increased more after RYGB than LAGB (CTX +221 ± 60% vs +15 ± 6%, P<0.001; P1NP +93 ± 25% vs -9 ± 10%, P < .001) and weight loss was greater with RYGB. Changes in CTX were independent of PTH and 25-hydroxyvitamin D but were associated with increases in fasting PYY. Postprandial suppression of CTX was more pronounced after RYGB than LAGB at 10 days and 1 year postoperatively.
Conclusions: RYGB is accompanied by early increases in fasting indices of bone remodeling, independent of weight loss or changes in PTH or 25-hydroxyvitamin D. LAGB did not affect bone markers. PYY and other enterohormonal signals may play a role in RYGB-specific skeletal changes.
Figures
Similar articles
-
Feeding and bone turnover in gastric bypass.J Clin Endocrinol Metab. 2014 Feb;99(2):491-7. doi: 10.1210/jc.2013-1308. Epub 2013 Nov 25. J Clin Endocrinol Metab. 2014. PMID: 24276463
-
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.Int J Obes (Lond). 2009 Jul;33(7):786-95. doi: 10.1038/ijo.2009.79. Epub 2009 May 5. Int J Obes (Lond). 2009. PMID: 19417773 Free PMC article.
-
Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.Diabetes Care. 2017 Jan;40(1):7-15. doi: 10.2337/dc16-1376. Epub 2016 Nov 8. Diabetes Care. 2017. PMID: 27999001 Free PMC article.
-
Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.Int J Clin Pract Suppl. 2010 Feb;(166):53-8. doi: 10.1111/j.1742-1241.2009.02279.x. Int J Clin Pract Suppl. 2010. PMID: 20377665 Review.
-
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Dan Med J. 2015 Apr;62(4):B5057. Dan Med J. 2015. PMID: 25872541 Review.
Cited by
-
The associations of gut microbiota, endocrine system and bone metabolism.Front Microbiol. 2023 Apr 6;14:1124945. doi: 10.3389/fmicb.2023.1124945. eCollection 2023. Front Microbiol. 2023. PMID: 37089533 Free PMC article. Review.
-
Changes in Bone Turnover Markers after Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: a Systematic Review and Meta-Analysis.Obes Surg. 2023 Apr;33(4):1259-1269. doi: 10.1007/s11695-023-06503-8. Epub 2023 Feb 15. Obes Surg. 2023. PMID: 36790646 Review.
-
The PYY/Y2R-deficient male mouse is not protected from bone loss due to Roux-en-Y gastric bypass.Bone. 2023 Feb;167:116608. doi: 10.1016/j.bone.2022.116608. Epub 2022 Nov 8. Bone. 2023. PMID: 36368466 Free PMC article.
-
Bone Response to Weight Loss Following Bariatric Surgery.Front Endocrinol (Lausanne). 2022 Jul 7;13:921353. doi: 10.3389/fendo.2022.921353. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35873004 Free PMC article. Review.
-
Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.Nutrients. 2021 Sep 14;13(9):3197. doi: 10.3390/nu13093197. Nutrients. 2021. PMID: 34579074 Free PMC article. Clinical Trial.
References
-
- Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2009;19:41–46. - PubMed
-
- Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5:444–449. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 8UL1TR000170-05/TR/NCATS NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- P30-DK036836/DK/NIDDK NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
- R56-DK095451/DK/NIDDK NIH HHS/United States
- RC1 DK086918/DK/NIDDK NIH HHS/United States
- K23-DK093713/DK/NIDDK NIH HHS/United States
- K23 DK093713/DK/NIDDK NIH HHS/United States
- UL1 TR000170/TR/NCATS NIH HHS/United States
- RC1-DK086918/DK/NIDDK NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- UL1 RR 025758/RR/NCRR NIH HHS/United States
- K12 HD051959/HD/NICHD NIH HHS/United States
- R56 DK095451/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
